Pixium Vision SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pixium Vision SA - overview
Established
2011
Location
Paris, -, France
Primary Industry
Medical Devices & Equipment
About
Pixium Vision SA specializes in developing advanced medical technologies aimed at restoring vision in patients suffering from advanced macular degeneration. Their innovative solutions enhance visual perception using retinal implants and camera-equipped glasses. Founded in 2011 in Paris, France, Pixium Vision SA focuses on the design and development of vision restoration technologies. The company has executed four significant deals throughout its operations.
CEO Lloyd Diamond has steered the company through its strategic initiatives, leading to its recent IPO in which the firm raised EUR 34. 50 mn, marking the total amount raised at EUR 34. 50 mn from various funding rounds. Pixium Vision SA's primary product is the PRIMA System, specifically designed to address advanced macular degeneration (AMD).
This system includes a retinal implant that interacts with glasses equipped with a camera, enabling users to perceive visual information and regain some lost visual capabilities. The company targets hospitals and ophthalmology clinics across Europe, with a focus on markets in France, Germany, and Italy, striving to improve the quality of life for individuals affected by AMD. In 2022, Pixium Vision SA reported a revenue of EUR 0, with an EBITDA of EUR -14,788,349. 80.
Their revenue generation model primarily relies on partnerships with healthcare facilities and direct sales of the PRIMA System to medical institutions, which includes structured contracts covering support, maintenance, and staff training. Pixium Vision SA plans to leverage its recent funding to advance the development of upcoming products aimed at enhancing visual restoration technologies. The company is also exploring expansion into additional European markets, seeking to broaden its reach by the end of 2024. Recent investment from Kreos Capital will support these initiatives as they aim to improve patient access to their innovative solutions.
Current Investors
Kreos Capital, Abingworth, Global Life Science Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Medical Devices & Equipment
Website
www.pixium-vision.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Pixium Vision SA - timeline of key events
Pixium Vision SA - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | 24,000 | 113,200 | - | 35,520 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 371.7% | (100.0%) | - | - | - | - |
| EBITDA (USD) | (11,624,879) | (16,866,879) | (13,024,231) | (12,460,643) | (8,962,582) | (9,716,843) | - | - | - |
| Operating Income (USD) | (12,429,258) | (17,787,592) | (14,074,245) | (13,423,027) | (10,282,040) | (10,165,131) | - | - | - |
| Operating Margin | - | - | (58642.7%) | (11857.8%) | - | (28618.0%) | - | - | - |
| % EBITDA Margin | - | - | (54267.6%) | (11007.6%) | - | (27356.0%) | - | - | - |
| NET Income (USD) | (10,444,850) | (15,473,017) | (12,158,829) | (12,100,804) | (14,443,183) | (9,277,037) | - | - | - |
| % Net Margin | - | - | (50661.8%) | (10689.8%) | - | (26117.8%) | - | - | - |
Pixium Vision SA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Pixium Vision SA | - |
Displaying 1 - 1 of 1
Pixium Vision SA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.